Phosphoric Acid

CHEMBL1187 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
98.0 g/mol
LogP
-2.1
Phase
4

Phosphoric acid is an inorganic acid used in pharmaceutical formulations primarily as a pH-adjusting agent and acidulant, and has also been used in very dilute concentrations as an antiemetic for nausea and vomiting. It plays a physiological role in buffering systems and serves as a source of phosphate ions used in various electrolyte replacement preparations.

分子量

97.9950 g/mol

LogP

-2.10

TPSA

77.80 Ų

リピンスキーの五則

適合

治療領域

作用機序

Provides essential ions for maintaining fluid balance, nerve conduction, muscle contraction, and acid-base homeostasis. Supplementation corrects electrolyte imbalances.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Provides essential ions for maintaining fluid balance, nerve conduction, muscle contraction, and acid-base homeostasis. Supplementation corrects electrolyte imbalances.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=P(O)(O)O

InChI

InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)

Molecular Formula

H3O4P

HBD / HBA

3 / 4

回転可能結合数

0

重原子数

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Phosphoric acid is an inorganic acid used in pharmaceutical formulations primarily as a pH-adjusting agent and acidulant, and has also been used in very dilute concentrations as an antiemetic for nausea and vomiting. It plays a physiological role in buffering systems and serves as a source of phosphate ions used in various electrolyte replacement preparations.

Provides essential ions for maintaining fluid balance, nerve conduction, muscle contraction, and acid-base homeostasis. Supplementation corrects electrolyte imbalances.

Yes, Phosphoric Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1187. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1004. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.